866-997-4948(US-Canada Toll Free)

Mycoplasma Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Published By :

Transparency Market Research

Published Date : Apr 2017

Category :

In Vitro Diagnostics

No. of Pages : 212 Pages

Global Mycoplasma Diagnostics Market: Overview

This report on mycoplasma diagnostics studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various mycoplasma techniques and products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global mycoplasma diagnostics market with respect to the leading market segments based on major products, key techniques, end-users, and geographies.

Global Mycoplasma Diagnostics Market: Scope of the Report

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global mycoplasma diagnostic market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products/techniques /end-users/geographies. The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the report. The section also includes completion matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Global Mycoplasma Diagnostics Market: Key Segments

The global mycoplasma diagnostics market has been studied based on major product segments, technique segment, their end-users, and regional as well as national markets. Based on product type, the global market has been categorized into three major 4 segments: Kits & reagents, instruments, software’s & services. On the basis of technology the mycoplasma diagnostics market are classified as PCR (Polymerase Chain Reaction), Immunoassay (ELISA, RIA), DNA staining, Microbial Culture Techniques, Others. On the basis of end users the market has been classified as hospitals, diagnostic laboratories, clinics and others.

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

Global Mycoplasma Diagnostics Market: Regional Outlook

Geographically, the mycoplasma diagnostic market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for microfluidics has been further categorized into major product, technology, and end-user segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

Companies Mentioned in the Report

The report also profiles key players operating in the microfluidics market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Agilent Technologies, Sartorius Stedim BioOutsource Limited, Savyon Diagnostics, Takara Bio Inc. (Takara Holding Company Inc.), Lonza Group, Merck KGaA, and Charles River Laboratories International, Inc. among others.

The global mycoplasma diagnostics market is segmented as follows:

Mycoplasma Diagnostics Market, by Product

  • Kits & Reagents
  • Instruments
  • Software & Services

Mycoplasma Diagnostics Market, by Technology

  • PCR
  • Immunoassay
  • ELISA
  • RIA
  • DNA staining
  • Microbial Culture Techniques
  • Others

Mycoplasma Diagnostics Market, by End Users

  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Others

Global Multiplexed Diagnostics Market, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Conten

1 Preface
1.1 Report Scope
1.2 Market Segmentation
1.3 Research Highlights

2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Acronyms Used
2.3 Research Methodology

3 Executive Summary

4 Market Overview
4.1 Global Mycoplasma Diagnostic Market Snapshot
4.2 Key Industry Events
4.3 Market Indicators

5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunity Analysis
5.5 Opportunities
5.6 Porter’s Five Forces Analysis
5.7 Value Chain Analysis
5.8 Global Mycoplasma Diagnostics Market Analysis and Forecast (US$ Mn), 2014–2024
5.9 Global Mycoplasma Diagnostics Market Market Outlook
5.10 Patents & Product Launch Analysis in Diagnostics
5.11 Advantages, Disadvantages, & the Availability of Select Mycoplasma Diagnostic Methods
5.12 Product Distribution Strategies

6 Global Mycoplasma Diagnostics Market Analysis, by Product Type
6.1 Key Findings
6.2 Introduction
6.3 Global Mycoplasma Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2024
6.4 Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
6.5 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2015–2024
6.6 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2015–2024
6.7 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Software & Services, 2015–2024
6.8 Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Product Type
6.9 Key Trends

7 Global Mycoplasma Diagnostics Market Analysis By Technology
7.1 Key Findings
7.2 Introduction
7.3 Global Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
7.4 Global Mycoplasma Diagnostics Market Value Share Analysis, by Immunoassay, 2016 and 2024
7.5 Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2024
7.6 Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology (Immunoassay), 2015–2024
7.7 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PCR, 2014–2024
7.8 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay, 2014–2024
7.9 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DNA Staining, 2014–2024
7.10 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microbial Culture Technique, 2014–2024
7.11 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2014–2024
7.12 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - ELISA, 2014–2024
7.13 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - RIA, 2014–2024
7.14 Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology
7.15 Key Trends

8 Global Mycoplasma Diagnostics Market Analysis, by End-user
8.1 Key Findings
8.2 Introduction
8.3 Global Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
8.4 Global Mycoplasma Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by End-user, 2014–2024
8.5 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Hospitals)
8.6 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Diagnostic Laboratories)
8.7 Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Clinics)
8.8 Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user
8.9 Key Trends

9 Global Mycoplasma Diagnostics Market Analysis By Region
9.1 Global Regulatory Scenario
9.2 Global Mycoplasma Diagnostics Market Value Share Analysis By Region Type, 2016 and 2024
9.3 Global Mycoplasma Diagnostics Market Size (US$ Mn)) Forecast, By Region Type, 2014–2024
9.4 Global Mycoplasma Diagnostics Market Attractiveness Analysis, By Region Type

10 North America Mycoplasma Diagnostics Market Analysis
10.1 Key Findings
10.2 North America Mycoplasma Diagnostics Market Overview
10.3 North America Market Value Share Analysis By Country, 2016 and 2024
10.4 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
10.5 North America Market Value Share Analysis By Product Type, 2016 and 2024
10.6 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
10.7 North America Market Value Share Analysis By Technology , 2016 and 2024
10.8 North America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
10.9 North America Market Value Share Analysis By Technology , 2016 and 2024
10.10 North America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
10.11 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology
10.12 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
10.13 North America Mycoplasma Diagnostics Market Value Share Analysis By End Users , 2016 and 2024
10.14 North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User , 2015–2024
10.15 North America Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
10.16 North America Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
10.17 North America Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

11 Europe Mycoplasma Diagnostics Market Analysis
11.1 Key Findings
11.2 Europe Mycoplasma Diagnostics Market Overview
11.3 Europe Market Value Share Analysis By Country, 2016 and 2024
11.4 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
11.5 Europe Market Value Share Analysis By Product Type, 2016 and 2024
11.6 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
11.7 Europe Market Value Share Analysis By Technology , 2016 and 2024
11.8 Europe Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
11.9 Europe Market Value Share Analysis By Technology , 2016 and 2024
11.10 Europe Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
11.11 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology
11.12 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
11.13 Europe Mycoplasma Diagnostics Market Value Share Analysis By End Users,  2016 and 2024
11.14 Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
11.15 Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
11.16 Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
11.17 Europe Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

12 Asia Pacific  Mycoplasma Diagnostics Market Analysis
12.1 Key Findings
12.2 Asia Pacific  Mycoplasma Diagnostics Market Overview
12.3 Asia Pacific  Market Value Share Analysis By Country, 2016 and 2024
12.4 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
12.5 Asia Pacific  Market Value Share Analysis By Product Type, 2016 and 2024
12.6 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
12.7 Asia Pacific  Market Value Share Analysis By Technology , 2016 and 2024
12.8 Asia Pacific  Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
12.9 Asia Pacific  Market Value Share Analysis By Technology , 2016 and 2024
12.10 Asia Pacific  Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
12.11 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology
12.12 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
12.13 Asia Pacific  Mycoplasma Diagnostics Market Value Share Analysis By End Users , 2016 and 2024
12.14 Asia Pacific  Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User , 2015–2024
12.15 Asia Pacific  Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
12.16 Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
12.17 Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

13 Latin America Mycoplasma Diagnostics Market Analysis
13.1 Key Findings
13.2 Latin America Mycoplasma Diagnostics Market Overview
13.3 Latin America Market Value Share Analysis By Country, 2016 and 2024
13.4 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
13.5 Latin America Market Value Share Analysis By Product Type, 2016 and 2024
13.6 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
13.7 Latin America Market Value Share Analysis By Technology , 2016 and 2024
13.8 Latin America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
13.9 Latin America Market Value Share Analysis By Technology , 2016 and 2024
13.10 Latin America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology , 2016 and 2024
13.11 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology
13.12 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology , 2014–2024
13.13 Latin America Mycoplasma Diagnostics Market Value Share Analysis By End Users , 2016 and 2024
13.14 Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User , 2015–2024
13.15 Latin America Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
13.16 Lain America Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
13.17 Latin America Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

14 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Analysis
14.1 Key Findings
14.2 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Overview
14.3 Middle East & Africa (MEA) Market Value Share Analysis By Country, 2016 and 2024
14.4 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
14.5 Middle East & Africa (MEA) Market Value Share Analysis By Product Type, 2016 and 2024
14.6 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
14.7 Middle East & Africa (MEA) Market Value Share Analysis By Technology, 2016 and 2024
14.8 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
14.9 Middle East & Africa (MEA) Market Value Share Analysis By Technology, 2016 and 2024
14.10 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
14.11 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology
14.12 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
14.13 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Value Share Analysis By End Users, 2016 and 2024
14.14 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
14.15 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type
14.16 Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
14.17 Middle East & Africa (MEA) Mycoplasma Diagnostics Market Attractiveness Analysis By End Users

15 Competition Landscape
15.1 Global Mycoplasma Diagnostics Market Share Analysis, by Company, 2016
15.2 Competition Matrix

16 Company Profiles
16.1 Agilent Technologies, Inc
16.1.1 Company Overview
16.1.2 Business Overview
16.1.3 Financial Overview
16.1.4 SWOT Analysis
16.1.5 Strategic Overview
16.2 Thermo Fisher Scientific Inc
16.2.1 Company Overview
16.2.2 Business Overview
16.2.3 Financial Overview
16.2.4 SWOT Analysis
16.2.5 Strategic Overview
16.3 PromoCell GmbH
16.3.1 Company Overview
16.3.2 Business Overview
16.3.3 Financial Overview
16.3.4 SWOT Analysis
16.3.5 Strategic Overview
16.4 Charles River Laboratories International, Inc
16.4.1 Company Overview
16.4.2 Business Overview
16.4.3 Financial Overview
16.4.4 SWOT Analysis
16.4.5 Strategic Overview
16.5 Merck KGaA
16.5.1 Company Overview
16.5.2 Business Overview
16.5.3 Financial Overview
16.5.4 SWOT Analysis
16.5.5 Strategic Overview
16.6 Lonza Group
16.6.1 Company Overview
16.6.2 Business Overview
16.6.3 Financial Overview
16.6.4 SWOT Analysis
16.6.5 Strategic Overview
16.7 Takara Bio Inc (Takara Holding Company Inc.)
16.7.1 Company Overview
16.7.2 Business Overview
16.7.3 Financial Overview
16.7.4 SWOT Analysis
16.7.5 Strategic Overview
16.8 Savyon Diagnostics
16.8.1 Company Overview
16.8.2 Business Overview
16.8.3 Financial Overview
16.8.4 SWOT Analysis
16.8.5 Strategic Overview
16.9 Tecan Trading AG (Tecan Group)
16.9.1 Company Overview
16.9.2 Business Overview
16.9.3 Financial Overview
16.9.4 SWOT Analysis
16.9.5 Strategic Overview
16.10 Sartorius Stedim BioOutsource Limited
16.10.1 Company Overview
16.10.2 Business Overview
16.10.3 Financial Overview
16.10.4 SWOT Analysis
16.10.5 Strategic Overview
16.11 American Type Culture Collection (ATCC)
16.11.1 Company Overview
16.11.2 Business Overview
16.11.3 Financial Overview
16.11.4 SWOT Analysis
16.11.5 Strategic Overview
16.12 F Hoffmann-La Roche Ltd
16.12.1 Company Overview
16.12.2 Business Overview
16.12.3 Financial Overview
16.12.4 SWOT Analysis
16.12.5 Strategic Overview

List of Table

Table 01: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 02: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2024
Table 03: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2015–2024
Table 04: Global Mycoplasma Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by End-user, 2015–2024
Table 05: Global Mycoplasma Diagnostics Market Size (US$ Mn)) Forecast, by Region, 2014–2024
Table 06: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 07: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 08: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 09: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 10: North America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 11: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2014–2024
Table 12: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 13: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
Table 14: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 15: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 16: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 17: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 18: Asia Pacific Market Size (US$ Mn) Forecast, by Technology, 2014–2024
Table 19: Asia Pacific Market Size (US$ Mn) Forecast, by Immunoassay, 2015–2024
Table 20: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2015–2024
Table 21: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, By Country, 2014–2024
Table 22: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2015–2024
Table 23: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
Table 24: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 25: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2014–2024
Table 26: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Country, 2014–2024
Table 27: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Product Type, 2014–2024
Table 28: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2014–2024
Table 29: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By Technology, 2015–2024
Table 30: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, By End User, 2015–2024

List of Chart

Figure 1: Global Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Global Mycoplasma Diagnostics Market Value Share, by Product Type (2016)
Figure 3: Global Mycoplasma Diagnostics Market Value Share, by technology (2016) 
Figure 4: Global Mycoplasma Diagnostics Market Value Share, by Region (2016)
Figure 5: Global Mycoplasma Diagnostics Market Value Share, by End-user (2016) 
Figure 06: Global Mycoplasma Diagnostics Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 07: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2015–2024
Figure 08: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2015–2024
Figure 09: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Software & Services, 2015–2024
Figure 10: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Product Type
Figure 11: Global Mycoplasma Diagnostics Market Value Share Analysis, by Technology, 2016 and 2024
Figure 12: Global Mycoplasma Diagnostics Market Value Share Analysis, by Immunoassay, 2016 and 2024
Figure 13: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PCR, 2014–2024
Figure 14: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay, 2014–2024
Figure 15: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DNA Staining, 2014–2024
Figure 16: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microbial Culture Technique, 2014–2024
Figure 17: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2014–2024
Figure 18: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - ELISA, 2014–2024
Figure 19: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay - RIA, 2014–2024
Figure 20: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology
Figure 21: Global Mycoplasma Diagnostics Market Value Share Analysis, by End-user, 2016 and 2024
Figure 22: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Hospitals)
Figure 23: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Diagnostic Laboratories)
Figure 24: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (Clinics)
Figure 25: Global Mycoplasma Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024 (By Others)
Figure 26: Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user
Figure 27: Global Mycoplasma Diagnostics Market Value Share Analysis, by Region, 2016 and 2024
Figure 28: Global Mycoplasma Diagnostics Market Attractiveness Analysis, by Region
Figure 29: North America Market Size (US$ Mn) Forecast, 2015–2024
Figure 30: North America Market Size Y-o-Y Growth Projections, 2015–2024
Figure 31: North America Market Value Share Analysis By Country, 2016 and 2024
Figure 32: North America Market Value Share Analysis By Product Type, 2016 and 2024
Figure 33: North America Market Value Share Analysis By Technology, 2016 and 2024
Figure 34: North America Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
Figure 35: North America Mycoplasma Diagnostics Market Value Share Analysis By End Users, 2016 and 2024
Figure 36: North America Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type 
Figure 37: North America Market Attractiveness Analysis By Technology
Figure 38: North America Market Attractiveness Analysis By End Users
Figure 39: Europe Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 40: Europe Mycoplasma Diagnostics Market attractiveness by country.
Figure 41: Europe Market Value Share Analysis By Country, 2016 and 2024
Figure 42: Europe Market Value Share Analysis By Product Type, 2016 and 2024
Figure 43: Europe Market Value Share Analysis By Technology, 2016 and 2024
Figure 44: Europe Mycoplasma Diagnostics Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
Figure 45: Europe Market Value Share Analysis By End Users, 2016 and 2024
Figure 46: Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Product Type 
Figure 47: Europe Mycoplasma Diagnostics Market Attractiveness Analysis By Technology
Figure 48: Europe Mycoplasma Diagnostics Market Attractiveness Analysis By End Users
Figure 49: Asia Pacific Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 50: Asia Pacific Market Attractiveness Analysis By Country
Figure 51: Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
Figure 52: Asia Pacific Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 53: Asia Pacific Market Value Share Analysis, by Technology, 2016 and 2024
Figure 54: Asia Pacific Mycoplasma Diagnostics Market Value Share Analysis, by Immunoassay, 2016 and 2024
Figure 55: Asia Pacific Market Value Share Analysis, by End-user, 2016 and 2024
Figure 56: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Product Type
Figure 57: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by Technology
Figure 58: Asia Pacific Mycoplasma Diagnostics Market Attractiveness Analysis, by End-user
Figure 59: Latin America Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 60: Latin America Market attractiveness by country, 2015–2024
Figure 61: Latin America Market Value Share Analysis By Country, 2016 and 2024
Figure 62: Latin America Market Value Share Analysis By Product Type, 2016 and 2024
Figure 63: Latin America Market Value Share Analysis By Technology, 2016 and 2024
Figure 64: Latin America Market Value Share Analysis By Immunoassay Technology, 2016 and 2024
Figure 65: Latin America Market Value Share Analysis By End Users, 2016 and 2024
Figure 66: Latin America Market Attractiveness Analysis By Product Type 
Figure 67: Latin America Market Attractiveness Analysis By Technology
Figure 68: Latin America Market Attractiveness Analysis By End Users
Figure 69: Middle East & Africa Mycoplasma Diagnostics Market Size (US$ Mn) Forecast, 2015–2024
Figure 70: Middle East & Africa Mycoplasma Diagnostics Market Size Y-o-Y Growth Projections, 2015–2024
Figure 71: Middle East & Africa Market Value Share Analysis By Country, 2016 and 2024
Figure 72: Middle East & Africa Market Value Share Analysis By Product Type, 2016 and 2024
Figure 73: Middle East & Africa Market Value Share Analysis, by Technology, 2016 and 2024
Figure 74: Middle East & Africa Market Value Share Analysis, by Immunoassay, 2016 and 2024
Figure 75: Middle East & Africa Mycoplasma Diagnostics Market Value Share Analysis By End Users, 2016 and 2024
Figure 76: Middle East & Africa Market Attractiveness Analysis By Product Type 
Figure 77: Middle East & Africa Market Attractiveness Analysis By Technology
Figure 78: Middle East & Africa Mycoplasma Diagnostics Market Attractiveness Analysis By End Users
Figure 79: Global Market Share Analysis, by Company, 2016 (Estimated)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *